Skip to main content

Table 2 Intraoperative blood gas analysis among three groups

From: High-flow nasal cannula improves clinical efficacy of airway management in patients undergoing awake craniotomy

Variables

Sample collection time point

HFNC 40

(n = 22)

HFNC 60

(n = 20)

NPA

(n = 23)

SpO2

Before induction of anesthesia

98.2 ± 1.4

97.4 ± 2.0

97.5 ± 1.2

 

15 min after induction of anesthesia

99.4 ± 1.0

99.6 ± 0.5

99.8 ± 0.4

 

15 min after achieving position

99.6 ± 0.7

99.5 ± 0.6

99.7 ± 0.6

 

End of dura suspension

99.6 ± 0.7

99.6 ± 0.5

99.8 ± 0.4

 

Cortical functional mapping

99.5 ± 0.8

99.8 ± 0.3

99.9 ± 0.2

 

15 min after re-induction

99.7 ± 0.7

99.6 ± 0.6

99.7 ± 0.5

PaCO2

Before induction of anesthesia

39.4 ± 3.7

38.6 ± 4.7

39.5 ± 4.9

 

15 min after induction of anesthesia

46.2 ± 4.6

45.8 ± 7.3

49.6 ± 6.6

 

15 min after achieving position

48.0 ± 4.3

47.9 ± 6.3

50.7 ± 6.2

 

End of dura suspension

50.2 ± 4.1

49.2 ± 6.1

51.7 ± 6.2

 

Cortical functional mapping

44.1 ± 2.8

42.3 ± 4.9

43.6 ± 5.9

 

15 min after re-induction

47.0 ± 4.3

46.0 ± 5.0

48.3 ± 5.4

PaO2/FiO2

Before induction of anesthesia

451.8 ± 69.4

421.9 ± 112.7

447.8 ± 64.9

 

15 min after induction of anesthesia

475.5 ± 81.7

496.00 ± 80.54

332.1 ± 115.0*#

 

15 min after achieving position

500.5 ± 93.6

499.45 ± 73.21

376.9 ± 92.1*#

 

End of dura suspension

477.6 ± 103.8

464.2 ± 90.8

384.3 ± 98.6*#

 

Cortical functional mapping

475.0 ± 106.1

465.4 ± 78.0

275.1 ± 92.8*#

 

15 min after re-induction

488.1 ± 100.4

494.7 ± 81.0

315.6 ± 93.9*#

  1. Data were expressed as mean ± SD. *P < 0.05 compared with HFNC 40 group; #P < 0.05 compared with HFNC 60 group. HFNC: high-flow nasal cannula; NPA: nasopharyngeal airway